Use the form below to register to join the team at Kepler Trust Intelligence and fund managers running money across a range of different asset classes and strategies, all seeking a reliable income for investors against a backdrop of rising inflation and volatile equity markets.
About our speakers
M&G Credit Income | MGCI
M&G Credit Income offers investors an income linked to interest rates, aiming to generate a yield of at least 4% over the interbank rate. The trust, which currently yields a 3.2% dividend yield, invests across the fixed income universe, in private debt as well as public, offering exposure to sectors more commonly available to institutional investors. Much of the portfolio is floating rate, which means the income available to pay the dividend could potentially rise as central banks raise rates.
Invesco Bond Income Plus | BIPS
Invesco Bond Income Plus aims to generate a high level of income and capital growth via a portfolio of high yield bonds, diversified across numerous countries and industries. BIPS is another of the highest yielding vehicles we will hear from this week, offering a dividend yield of 6.2%.
International Biotechnology Trust | IBT
International Biotechnology is primarily formed of listed equities in the biotech space, plus a small allocation toward unquoted companies, and converts some of the capital growth it generates into income using a unique feature of the investment trust structure, offering a yield equivalent to 4% of NAV. The managers have increased gearing recently to take advantage of what they see as bombed out valuations in a market with great potential for a rebound.
Edinburgh Investment Trust | EDIN
Edinburgh Investment Trust is one of the oldest and best-known UK equity income trusts in the business. We will find out where the management team plans to take it as fund manager James de Uphaugh continues his stewardship of the trust as head of the Global Fundamental team at Liontrust Asset Management, which bought former manager, Majedie where he was CIO, earlier this year. EDIN yields 3.9% via a portfolio wholly focused on UK equities.
JPMorgan Global Core Real Assets | JARA
JPMorgan Global Core Real Assets was launched in late 2019 – shortly before the global pandemic began to bite. Having survived this baptism of fire the trust, which invests in real assets across a broad mix including real estate, infrastructure and transport, has recorded strong returns over one year and has seen its discount narrow as a result. JARA’s shares yield 4.4%, with its portfolio now fully invested.
If you have any questions about this event, please contact [email protected]
Kepler Partners LLP considers this commentary to be a minor non-monetary benefit, as it:
1. Is intended to enhance the quality of service provided to you by us and is generic in nature;
2. Consists of short-term market commentary on the latest economic statistics and/or company results and/or information on upcoming releases or events;
3. Contains a brief summary of the author’s own opinion on such information;
4. Is not substantiated nor does it include any substantive analysis;
5. Reiterates the Kepler Partner LLP’s view on an existing recommendation or substantive research material; and/or
6. Is unlikely to impair your investment firm's compliance duty to act in the best interest of your client.
This report has been issued by Kepler Partners LLP for communication only to eligible counterparties and professional clients as defined by the Financial Conduct Authority. Its contents may not be suitable for and are not to be communicated to or be relied on by retail clients. It is not an indication as to the suitability or appropriateness of investing in the security or securities discussed.
Past performance is not a reliable indicator of future results. The value of investments can fall as well as rise and you may get back less than you invested when you decide to sell your investments. It is strongly recommended that Independent financial advice should be taken before entering into any financial transaction.
The information provided on this website is not intended for distribution to, or use by, any person or entity in any jurisdiction or country where such distribution or use would be contrary to law or regulation or which would subject Kepler Partners LLP to any registration requirement within such jurisdiction or country. In particular, this website is exclusively for non-US Persons. Persons who access this information are required to inform themselves and to comply with any such restrictions.
The information contained in this website is not intended to constitute, and should not be construed as, investment advice. No representation or warranty, express or implied, is given by any person as to the accuracy or completeness of the information and no responsibility or liability is accepted for the accuracy or sufficiency of any of the information, for any errors, omissions or misstatements, negligent or otherwise. Any views and opinions, whilst given in good faith, are subject to change without notice.
This is not an official confirmation of terms and is not a recommendation, offer or solicitation to buy or sell or take any action in relation to any investment mentioned herein. Any prices or quotations contained herein are indicative only.
Kepler Partners LLP (including its partners, employees and representatives) or a connected person may have positions in or options on the securities detailed in this report, and may buy, sell or offer to purchase or sell such securities from time to time, but will at all times be subject to restrictions imposed by the firm’s internal rules. A copy of the firm’s Conflict of Interest policy is available on request.
PLEASE SEE ALSO OUR TERMS AND CONDITIONS
Kepler Partners LLP is authorised and regulated by the Financial Conduct Authority (FRN 480590), registered in England and Wales at 70 Conduit Street, London W1S 2GF with registered number OC334771.
